Radiotherapy as palliative treatment for metastatic melanoma

This study aimed to assess the response rate and efficacy of palliative radiation therapy in patients with metastatic melanoma. From 1993 to 1999, 28 patients with 35 irradiated areas were treated with palliative radiotherapy for metastatic melanoma in the Radiotherapy Department of the Henri Mondor...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Melanoma research 1999-12, Vol.9 (6), p.611-613
Hauptverfasser: Kirova, Y M, Chen, J, Rabarijaona, L I, Piedbois, Y, Le Bourgeois, J P
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 613
container_issue 6
container_start_page 611
container_title Melanoma research
container_volume 9
creator Kirova, Y M
Chen, J
Rabarijaona, L I
Piedbois, Y
Le Bourgeois, J P
description This study aimed to assess the response rate and efficacy of palliative radiation therapy in patients with metastatic melanoma. From 1993 to 1999, 28 patients with 35 irradiated areas were treated with palliative radiotherapy for metastatic melanoma in the Radiotherapy Department of the Henri Mondor University Hospital, Créteil, France. Of these, 19 (68%) patients had bone and soft tissue metastases, seven (25%) patients had brain metastases and two (7%) patients had both types of metastases. Most of the patients were treated with 30 Gy of irradiation in 10 fractions over 2 weeks or 20 Gy in five fractions over 1.5 weeks. Of those with bone metastases, 67% responded to palliative bone treatment with good pain relief and/or decompression. Of the patients with brain metastases, 57% had amelioration of neurological function deficits, 29% did not respond, and one patient showed aggravation of his disease and did not finish the course of irradiation. Two patients with unresectable disease obtained partial remission and good palliation of symptoms. In conclusion, short-course radiotherapy has a role to play in the palliation of metastatic melanoma, with good relief of symptoms.
doi_str_mv 10.1097/00008390-199912000-00012
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69422103</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69422103</sourcerecordid><originalsourceid>FETCH-LOGICAL-c311t-1dc8f4ced01f633c9232915bac206c4d18cb521d3eb4c2b10bb04d4fe3066d943</originalsourceid><addsrcrecordid>eNpNkEtLxDAQgHNQ3HX1L0hP3qqZTLZtwIssvmBBED2HPKZYabc1yQr7742uigPDvB98jBXAL4Cr-pJnaVDxEpRSIHJUZgVxwOZcVbxsFMKMHcf4lrM1LvGIzYBXFdS1nLOrJ-O7Mb1SMNOuMLGYTN93JnUfVKRAJg20SUU7hmKgZGLKFZfd3mzGwZyww9b0kU5_7IK93N48r-7L9ePdw-p6XToESCV417TSkefQVohOCRQKltY4wSsnPTTOLgV4JCudsMCt5dLLljC_6ZXEBTvf753C-L6lmPTQRUd9_oLGbdSVkkIAx9zY7BtdGGMM1OopdIMJOw1cf9HSv7T0Hy39TSuPnv3c2NqB_L_BPSr8BAEOZ3A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69422103</pqid></control><display><type>article</type><title>Radiotherapy as palliative treatment for metastatic melanoma</title><source>Journals@Ovid Ovid Autoload</source><source>MEDLINE</source><creator>Kirova, Y M ; Chen, J ; Rabarijaona, L I ; Piedbois, Y ; Le Bourgeois, J P</creator><creatorcontrib>Kirova, Y M ; Chen, J ; Rabarijaona, L I ; Piedbois, Y ; Le Bourgeois, J P</creatorcontrib><description>This study aimed to assess the response rate and efficacy of palliative radiation therapy in patients with metastatic melanoma. From 1993 to 1999, 28 patients with 35 irradiated areas were treated with palliative radiotherapy for metastatic melanoma in the Radiotherapy Department of the Henri Mondor University Hospital, Créteil, France. Of these, 19 (68%) patients had bone and soft tissue metastases, seven (25%) patients had brain metastases and two (7%) patients had both types of metastases. Most of the patients were treated with 30 Gy of irradiation in 10 fractions over 2 weeks or 20 Gy in five fractions over 1.5 weeks. Of those with bone metastases, 67% responded to palliative bone treatment with good pain relief and/or decompression. Of the patients with brain metastases, 57% had amelioration of neurological function deficits, 29% did not respond, and one patient showed aggravation of his disease and did not finish the course of irradiation. Two patients with unresectable disease obtained partial remission and good palliation of symptoms. In conclusion, short-course radiotherapy has a role to play in the palliation of metastatic melanoma, with good relief of symptoms.</description><identifier>ISSN: 0960-8931</identifier><identifier>DOI: 10.1097/00008390-199912000-00012</identifier><identifier>PMID: 10661774</identifier><language>eng</language><publisher>England</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Male ; Melanoma - radiotherapy ; Melanoma - secondary ; Middle Aged ; Palliative Care ; Treatment Outcome</subject><ispartof>Melanoma research, 1999-12, Vol.9 (6), p.611-613</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c311t-1dc8f4ced01f633c9232915bac206c4d18cb521d3eb4c2b10bb04d4fe3066d943</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10661774$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kirova, Y M</creatorcontrib><creatorcontrib>Chen, J</creatorcontrib><creatorcontrib>Rabarijaona, L I</creatorcontrib><creatorcontrib>Piedbois, Y</creatorcontrib><creatorcontrib>Le Bourgeois, J P</creatorcontrib><title>Radiotherapy as palliative treatment for metastatic melanoma</title><title>Melanoma research</title><addtitle>Melanoma Res</addtitle><description>This study aimed to assess the response rate and efficacy of palliative radiation therapy in patients with metastatic melanoma. From 1993 to 1999, 28 patients with 35 irradiated areas were treated with palliative radiotherapy for metastatic melanoma in the Radiotherapy Department of the Henri Mondor University Hospital, Créteil, France. Of these, 19 (68%) patients had bone and soft tissue metastases, seven (25%) patients had brain metastases and two (7%) patients had both types of metastases. Most of the patients were treated with 30 Gy of irradiation in 10 fractions over 2 weeks or 20 Gy in five fractions over 1.5 weeks. Of those with bone metastases, 67% responded to palliative bone treatment with good pain relief and/or decompression. Of the patients with brain metastases, 57% had amelioration of neurological function deficits, 29% did not respond, and one patient showed aggravation of his disease and did not finish the course of irradiation. Two patients with unresectable disease obtained partial remission and good palliation of symptoms. In conclusion, short-course radiotherapy has a role to play in the palliation of metastatic melanoma, with good relief of symptoms.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Melanoma - radiotherapy</subject><subject>Melanoma - secondary</subject><subject>Middle Aged</subject><subject>Palliative Care</subject><subject>Treatment Outcome</subject><issn>0960-8931</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpNkEtLxDAQgHNQ3HX1L0hP3qqZTLZtwIssvmBBED2HPKZYabc1yQr7742uigPDvB98jBXAL4Cr-pJnaVDxEpRSIHJUZgVxwOZcVbxsFMKMHcf4lrM1LvGIzYBXFdS1nLOrJ-O7Mb1SMNOuMLGYTN93JnUfVKRAJg20SUU7hmKgZGLKFZfd3mzGwZyww9b0kU5_7IK93N48r-7L9ePdw-p6XToESCV417TSkefQVohOCRQKltY4wSsnPTTOLgV4JCudsMCt5dLLljC_6ZXEBTvf753C-L6lmPTQRUd9_oLGbdSVkkIAx9zY7BtdGGMM1OopdIMJOw1cf9HSv7T0Hy39TSuPnv3c2NqB_L_BPSr8BAEOZ3A</recordid><startdate>19991201</startdate><enddate>19991201</enddate><creator>Kirova, Y M</creator><creator>Chen, J</creator><creator>Rabarijaona, L I</creator><creator>Piedbois, Y</creator><creator>Le Bourgeois, J P</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19991201</creationdate><title>Radiotherapy as palliative treatment for metastatic melanoma</title><author>Kirova, Y M ; Chen, J ; Rabarijaona, L I ; Piedbois, Y ; Le Bourgeois, J P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c311t-1dc8f4ced01f633c9232915bac206c4d18cb521d3eb4c2b10bb04d4fe3066d943</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Melanoma - radiotherapy</topic><topic>Melanoma - secondary</topic><topic>Middle Aged</topic><topic>Palliative Care</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kirova, Y M</creatorcontrib><creatorcontrib>Chen, J</creatorcontrib><creatorcontrib>Rabarijaona, L I</creatorcontrib><creatorcontrib>Piedbois, Y</creatorcontrib><creatorcontrib>Le Bourgeois, J P</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Melanoma research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kirova, Y M</au><au>Chen, J</au><au>Rabarijaona, L I</au><au>Piedbois, Y</au><au>Le Bourgeois, J P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Radiotherapy as palliative treatment for metastatic melanoma</atitle><jtitle>Melanoma research</jtitle><addtitle>Melanoma Res</addtitle><date>1999-12-01</date><risdate>1999</risdate><volume>9</volume><issue>6</issue><spage>611</spage><epage>613</epage><pages>611-613</pages><issn>0960-8931</issn><abstract>This study aimed to assess the response rate and efficacy of palliative radiation therapy in patients with metastatic melanoma. From 1993 to 1999, 28 patients with 35 irradiated areas were treated with palliative radiotherapy for metastatic melanoma in the Radiotherapy Department of the Henri Mondor University Hospital, Créteil, France. Of these, 19 (68%) patients had bone and soft tissue metastases, seven (25%) patients had brain metastases and two (7%) patients had both types of metastases. Most of the patients were treated with 30 Gy of irradiation in 10 fractions over 2 weeks or 20 Gy in five fractions over 1.5 weeks. Of those with bone metastases, 67% responded to palliative bone treatment with good pain relief and/or decompression. Of the patients with brain metastases, 57% had amelioration of neurological function deficits, 29% did not respond, and one patient showed aggravation of his disease and did not finish the course of irradiation. Two patients with unresectable disease obtained partial remission and good palliation of symptoms. In conclusion, short-course radiotherapy has a role to play in the palliation of metastatic melanoma, with good relief of symptoms.</abstract><cop>England</cop><pmid>10661774</pmid><doi>10.1097/00008390-199912000-00012</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0960-8931
ispartof Melanoma research, 1999-12, Vol.9 (6), p.611-613
issn 0960-8931
language eng
recordid cdi_proquest_miscellaneous_69422103
source Journals@Ovid Ovid Autoload; MEDLINE
subjects Adult
Aged
Aged, 80 and over
Female
Humans
Male
Melanoma - radiotherapy
Melanoma - secondary
Middle Aged
Palliative Care
Treatment Outcome
title Radiotherapy as palliative treatment for metastatic melanoma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T03%3A42%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Radiotherapy%20as%20palliative%20treatment%20for%20metastatic%20melanoma&rft.jtitle=Melanoma%20research&rft.au=Kirova,%20Y%20M&rft.date=1999-12-01&rft.volume=9&rft.issue=6&rft.spage=611&rft.epage=613&rft.pages=611-613&rft.issn=0960-8931&rft_id=info:doi/10.1097/00008390-199912000-00012&rft_dat=%3Cproquest_cross%3E69422103%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69422103&rft_id=info:pmid/10661774&rfr_iscdi=true